|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Blood, 1 July 2004, Vol. 104, No. 1, pp. 166-169. Prepublished online as a Blood First Edition Paper on March 16, 2004; DOI 10.1182/blood-2003-09-3293.
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Retinoic acid controls blood vessel formation by modulating endothelial and mural cell interaction via suppression of Tie2 signaling in vascular progenitor cellsFrom the Molecular Cellular Pathology Research Unit and the Laboratory of Molecular Cell Science, RIKEN (The Institute for Physical and Chemical Research), Wako, Saitama, Japan; the Department of Molecular Biology, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan; the Laboratory for Stem Cell Differentiation Regulation, Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University, Japan; the ANB Tsukuba Institute, Bioscience Business Center, ALOKA Co Ltd, Niihari, Ibaraki, Japan; the Experimental Animal Division, RIKEN BioResource Center, Tsukuba, Ibaraki, Japan; and INSERM U36, Collège de France, Paris, France.
Inhibition by all-trans retinoic acid (atRA) of the microvasculature formation in chicken chorioallantoic membrane (CAM) accompanied remarkably reduced numbers of endothelial cells (ECs) and increased numbers of mural cells (MCs) under the chorionic epithelial layer. Ro41-5253 (retinoid antagonist) exerted the opposite effect. Although atRA did not affect the differentiation of murine embryonic stem cell–derived vascular progenitor cells (VPCs) into ECs or MCs, atRA suppressed EC-MC interaction, leading to impaired branching. In both atRA-treated VPC cultures and CAM tissues underneath the chorionic epithelial layer, the expression of angiopoietin-2 (Ang-2; competitor for Ang-1) was enhanced, whereas that of Tie2 (a receptor for Angs) was reduced. Simultaneous treatment with Ang-1 partially blocked RA induction of EC-MC malinteraction and reduction in blood vessel formation. These results suggest that retinoid(s) may reduce EC-MC interaction by down-regulating Tie2 signaling as well as decreased EC numbers, which lead to impaired vascular remodeling.
Vasculogenesis is the formation of primitive vascular networks mainly through differentiation of vascular progenitor cells (VPCs) into endothelial cells (ECs), while angiogenesis is the growth and sprouting of additional blood vessels from pre-existing blood vessels.1-6 In either case, formation of blood vessel networks is completed by branching (remodeling) of blood vessels through interaction between ECs and surrounding mural cells (MCs; smooth muscle cells or pericytes),1-4 and tightly regulated by various factors (eg, vascular endothelial growth factor [VEGF], fibroblast growth factor [FGF], angiostatin, endostatin, and angiopoietins [Ang-1 and Ang-2]).2,4,7,8 Ang-1 sustains interaction between ECs and MCs and stabilizes the vasculature through binding to Tie2 receptor and up-regulation of its phosphorylation, although underlying detailed mechanisms have not been elucidated. Normally, Ang-2 counteracts the action of Ang-1 by competitively inhibiting its binding to Tie2.2,8 Retinoids (vitamin A and its derivatives) are reported to exert a potent antiangiogenic activity in the chorioallantoic membranes (CAMs) of growing chick embryos, although underlying mechanisms have been unclear.9 Here, we analyzed this mechanism using chicken CAM and mouse embryonic stem (ES)–derived VPCs.
Materials
AtRA (pan retinoic acid receptor [RAR] agonist) was purchased from Sigma-Aldrich (St Louis, MO). RAR Chicken CAM assay Chicken CAM was assessed as described.9 Angiogenic/antiangiogenic responses were quantitated using angiogenesis measuring software (KURABO Angiogenesis Image Analyzer version 1.0; Kurabo, Osaka, Japan). Data are expressed as the mean plus or minus the standard deviation (SD). Statistical significance was assessed with one-way analysis of variance followed by the Sheffe t test. Cell culture and sorting Maintenance, differentiation, and sorting of the CCE/nLacZ ES cell cultures were performed as described.6 The Flk1-positive (Flk1+) cells bound to the microbeads were collected using the autoMACS magnetic cell sorting system (Miltenyi Biotec, Auburn, CA) to yield purity of more than 95%. Human umbilical vein endothelial cells (HUVECs) were kindly provided by Professor K. Umezawa (Keio University, Yokohama, Japan) and cultured as described.11 Umbilical artery smooth muscle cells (UASMCs) were purchased from Cambrex Bio Science Walkersville (Walkersville, MD) and maintained according to the manufacturer's instructions. Immunohistochemistry
CAM tissues were fixed with 4% paraformaldehyde and embedded in either Technovit 8100 synthetic resin (Heraeus Kulzer, Wehrheim, Germany) or Tissue-Tek OCT compound (Miles, Elkhart, IN).12 Vertical sections (5 µm) were stained with hematoxylin and eosin and frozen sections (10 µm) were immunostained with a combination of either a mouse anti–Quek-1 monoclonal antibody, which recognizes the chicken Flk1/KDR/VEGFR2, or a murine antiproliferating cell nuclear antigen (PCNA) monoclonal antibody (Dako A/S, Glostrup, Denmark), which reacts with eukaryotic antigens in early S phase without discrimination between ECs and MCs, plus a murine anti- RNA extraction and reverse transcriptase–polymerase chain reaction (RT-PCR) Total RNA was extracted from microvasculatures, which were dissected out from vertical sections (15 µm) of CAM tissues using a Laser Micro Dissection LMD system (Leica Microsystems), or from cell cultures using the RNeasy Mini Kit (Qiagen, Valencia, CA). RT-PCR was carried out using SuperScript First-Strand Synthesis System (Invitrogen, Carlsbad, CA), and sets of specific primers summarized in Table 1. Quantitative PCR was performed using Light Cycler quantitative PCR system (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instruction.
Compared with control CAM (Figure 1Ai), atRA inhibited the formation of fine vascular networks and, instead, formed weaving networks of relatively larger vessels (Figure 1Aii [PDB] ), accompanying reduced number of paths, while Ro41-5253 stimulated the fine capillary formation (Figure 1Aiii) accompanying a slightly increased number of paths. In control CAM tissue, many capillaries, which were mainly composed of Flk1-expressing ECs and some  SMA-expressing MCs, developed underneath the chorionic epithelium (Figure 1Bi,iv). AtRA remarkably reduced the number of capillaries accompanying a loss of ECs and, instead, a strong expression of SMA in a decapillarized layer (Figure 1Bii
[PDB]
,v), and made several vessels scattered within the mesenchymal layer (arrowheads), whereas Ro41-5253 stimulated microvasculature formation with increased Flk1 signals and reduced SMA signals (Figure 1Biii,vi). Upon atRA treatment the number of PCNA-positive ECs reduced, but an increase in PCNA-positive MCs was not observed (Figure 1Bviii). Ro41-5253 augmented the number of PCNA-positive ECs in the microvasculatures (Figure 1Bix
[PDB]
). These data suggested that exogenous and endogenous retinoid might affect the vascular remodeling in addition to reducing EC numbers. Mouse embryos lacking Ang-1 or Tie2 exhibit a defect in remodeling function,16-18 which leads to interference with normal proliferation of newly differentiated ECs.19 Therefore, we examined an involvement of Ang-1 and Ang-2 in the antiangiogenic action of atRA (Figure 1C). Although Ang-1 alone did not affect blood vessel formation (Figure 1Civ
[PDB]
), simultaneous treatment with atRA and Ang-1 partially reverted the suppressive effect of atRA (compare Figure 1Cii
[PDB]
,v). In contrast, Ang-2 alone displayed a similar antiangiogenic action (Figure 1Ciii). We then examined whether atRA might affect the expression of angiopoietins and/or Tie2 mRNA in HUVECs or UASMCs, but the answer was no (data not shown). Therefore, we hypothesized that retinoid might act on VPCs rather than mature vascular cells. To explore this idea, we first examined the effect of atRA on ES cell–derived Flk1+ cells, which function as VPCs.6 Almost all Flk1+ cells differentiated into MCs in the absence of VEGF (Figure 2Ai,v). AtRA did not affect this (Figure 2Aii,vi). VEGF induced the differentiation of Flk1+ cells into ECs, whose surface was covered by several MCs (white arrowheads in Figure 2Aiii), and enhanced the formation of vascular tree–like structures composed of ECs and MCs (Figure 2Avii). Simultaneous stimulation of atRA and VEGF resulted in a separation of VEGF-induced ECs from MCs (Figure 2Aiv), and inhibited the branching of endothelial tubes and the attachment of MCs to ECs (black arrowheads in Figure 2Aviii). A similar result was obtained by a combination of VEGF plus Ang-2 (data not shown). As seen in Figure 2B, VEGF enhanced the mRNA expression of Flk1, PECAM-1, and endoglin (lane 3). Either alone (lane 2) or in conjunction with VEGF (lane 4), atRA up-regulated Ang-2 mRNA expression 14.0-fold and 8.2-fold, respectively, and down-regulated the expression of Ang-1 and Tie2 mRNAs (10% and 5%, 20%, and 70%, respectively). A similar result was also observed underneath the chorionic epithelium in CAM (Figure 2C). AtRA decreased mRNA levels of Flk1 by 45% and increased those of SMA and Ang-2 1.3-fold and 1.4-fold, respectively, while an antagonist decreased them to 45% and 20%, respectively. These results suggest that atRA may inhibit Tie2 signaling in VPCs by modulating the expression of Ang-2 and Tie2 mRNAs in opposite directions, leading to inhibition of EC-MC interaction and, subsequently, suppression of normal remodeling of blood vessels and reduction in EC cell numbers. Although impaired remodeling during vascular development might cause the dynamic change in the numbers of ECs and MCs underneath the chorionic epithelium (Figure 1B), other possibilities cannot be excluded. Especially, as transforming growth factor  (TGF-) signals are essential for both formation and maturation of blood vessels as well as for reduction in EC cell number,20-23 we are now examining a role of TGF- as a mediator of retinoid action, and a relationship between Tie2 and TGF- signal pathway.
We thank A. Uemura (Kyoto University, Japan) for his critical advice, and K. Umezawa and O. Ohno (Keio University, Yokohama, Japan) for a provision of HUVECs.
Submitted September 25, 2003; accepted March 1, 2004.
Prepublished online as Blood First Edition Paper, March 16, 2004; DOI 10.1182/blood-2003-09-3293.
Supported in part by the Grants-in-Aids for Young Scientists (B) (Y.S.), for Scientific Research (A) (A.Y.), and the Special Coordination Fund for the promotion of Science and Technology (S.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, as well as the Chemical Biology Research Project (S.K.) and Special Postdoctoral Research Program (Y.S.) from RIKEN.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Soichi Kojima, Molecular Cellular Pathology Research Unit, RIKEN, Wako, Saitama 351-0198, Japan; e-mail: skojima{at}postman.riken.go.jp.
  CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2004 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
, and 
represent significant difference (P < .05) obtained by comparing to control samples (i), samples treated with atRA (ii), and samples treated with Ang-2 (iii), respectively. For panels A to C, a total of 15 eggs (n = 5 x 3 times) for each experimental group were evaluated and representative results are shown.
